JP2023553563A5 - - Google Patents
Info
- Publication number
- JP2023553563A5 JP2023553563A5 JP2023536097A JP2023536097A JP2023553563A5 JP 2023553563 A5 JP2023553563 A5 JP 2023553563A5 JP 2023536097 A JP2023536097 A JP 2023536097A JP 2023536097 A JP2023536097 A JP 2023536097A JP 2023553563 A5 JP2023553563 A5 JP 2023553563A5
- Authority
- JP
- Japan
- Prior art keywords
- glp
- concentration
- composition according
- approximately
- benzalkonium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20214558.7 | 2020-12-16 | ||
| EP20214558 | 2020-12-16 | ||
| PCT/EP2021/086148 WO2022129312A1 (en) | 2020-12-16 | 2021-12-16 | Pharmaceutical composition of glp-1/glp-2 dual agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553563A JP2023553563A (ja) | 2023-12-22 |
| JP2023553563A5 true JP2023553563A5 (https=) | 2024-12-23 |
Family
ID=74141273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536097A Pending JP2023553563A (ja) | 2020-12-16 | 2021-12-16 | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230405088A1 (https=) |
| EP (1) | EP4262746A1 (https=) |
| JP (1) | JP2023553563A (https=) |
| KR (1) | KR20230121824A (https=) |
| CN (1) | CN116723850A (https=) |
| AU (1) | AU2021401137B2 (https=) |
| CA (1) | CA3196989A1 (https=) |
| CL (1) | CL2023001745A1 (https=) |
| IL (1) | IL301891A (https=) |
| MX (1) | MX2023006280A (https=) |
| TW (1) | TW202241491A (https=) |
| WO (1) | WO2022129312A1 (https=) |
| ZA (1) | ZA202304233B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202111311WA (en) | 2019-06-14 | 2021-12-30 | Zealand Pharma As | Pharmaceutical parenteral composition of dual glp1/2 agonist |
| IL301892A (en) * | 2020-12-16 | 2023-06-01 | Zealand Pharma As | Drug composition of dual GLP-1/GLP-2 agonists |
| JP2024533153A (ja) * | 2021-09-03 | 2024-09-12 | ジーランド ファーマ エー／エス | 投薬レジーム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU723268B2 (en) | 1996-09-09 | 2000-08-24 | Zealand Pharma A/S | Improved solid-phase peptide synthesis and agent for use in such synthesis |
| UA95235C2 (en) * | 2005-05-04 | 2011-07-25 | Зииланд Фарма А/С | Glucagon-like-peptide-2 (glp-2) analogues |
| IN2015DN00544A (https=) * | 2012-07-23 | 2015-06-26 | Zealand Pharma As | |
| KR20200080331A (ko) * | 2012-07-23 | 2020-07-06 | 질랜드 파마 에이/에스 | 글루카곤 유사체 |
| JP6822839B2 (ja) * | 2013-09-13 | 2021-01-27 | ザ・スクリップス・リサーチ・インスティテュート | 修飾された治療剤、及びその組成物 |
| KR102455171B1 (ko) * | 2013-12-18 | 2022-10-14 | 더 스크립스 리서치 인스티튜트 | 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물 |
| AR110300A1 (es) * | 2016-12-02 | 2019-03-13 | Sanofi Sa | Compuestos como agonistas peptídicos trigonales de los receptores de glp1 / glucagón / gip |
| EP3551651B1 (en) * | 2016-12-09 | 2024-03-06 | Zealand Pharma A/S | Acylated glp-1/glp-2 dual agonists |
-
2021
- 2021-12-16 MX MX2023006280A patent/MX2023006280A/es unknown
- 2021-12-16 JP JP2023536097A patent/JP2023553563A/ja active Pending
- 2021-12-16 EP EP21836186.3A patent/EP4262746A1/en active Pending
- 2021-12-16 IL IL301891A patent/IL301891A/en unknown
- 2021-12-16 KR KR1020237023829A patent/KR20230121824A/ko active Pending
- 2021-12-16 US US18/037,795 patent/US20230405088A1/en active Pending
- 2021-12-16 CN CN202180079922.4A patent/CN116723850A/zh active Pending
- 2021-12-16 WO PCT/EP2021/086148 patent/WO2022129312A1/en not_active Ceased
- 2021-12-16 CA CA3196989A patent/CA3196989A1/en active Pending
- 2021-12-16 AU AU2021401137A patent/AU2021401137B2/en active Active
- 2021-12-16 TW TW110147095A patent/TW202241491A/zh unknown
-
2023
- 2023-04-06 ZA ZA2023/04233A patent/ZA202304233B/en unknown
- 2023-06-14 CL CL2023001745A patent/CL2023001745A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023553563A5 (https=) | ||
| JP2023553561A5 (https=) | ||
| US20230218564A1 (en) | Peptide pharmaceuticals for treatment of nash and other disorders | |
| KR102691149B1 (ko) | 대사 및 간 질환 치료를 위한 조성물 및 방법 | |
| JP5669395B2 (ja) | 新規化合物および摂食行動に対するその効果 | |
| RU2012128547A (ru) | Дважды ацилированные производные glp-1 | |
| KR20240055145A (ko) | 대사 및 간 장애의 치료를 위한 조성물 및 방법 | |
| ES2973935T3 (es) | Triple agonista que tiene actividad con respecto a todos los receptores de glucagón, GLP-1 y GIP para el tratamiento de enfermedad hepática | |
| RU2019121280A (ru) | Glp-1/glp-2 двойные агонисты | |
| US20070232658A1 (en) | Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction | |
| JP2024533153A5 (https=) | ||
| KR20120125610A (ko) | 시클로스포린 유사체 | |
| JP2005532269A5 (https=) | ||
| KR20250044687A (ko) | Ask1 억제제를 이용한 장기 질환 또는 장애 치료 방법 | |
| JP2012523434A5 (https=) | ||
| CN120737188A (zh) | 作为长效glp-1/升糖素受体激动剂以治疗脂肪肝疾病及脂肪肝炎的升糖素类似物 | |
| IL315941A (en) | Uses of farnesoid x receptor agonists | |
| US20100028298A1 (en) | Interferon type i supporting compounds | |
| RU2021139206A (ru) | Фармацевтическая парентеральная композиция двойного агониста glp1/2 | |
| JP2024500343A (ja) | 腎不全患者におけるｇｌｐ－２アナログの使用 | |
| RU2021139211A (ru) | Фармацевтическая парентеральная композиция двойного агониста glp1/2 | |
| US20240197816A1 (en) | Composition and method for prolong survival of transplant and recipient | |
| NZ780977B2 (en) | Pharmaceutical parenteral composition of dual glp1/2 agonist | |
| CN1575173A (zh) | 含有大环内酯的药物组合物 | |
| Triantafillidis et al. | Absence of toxicity of ornidazole after a 10-yr continuous daily use for Crohn's disease |